Suzhou Novosense Microlectronics Co Ltd
SSE:688052
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Suzhou Novosense Microlectronics Co Ltd
SSE:688052
|
CN |
|
C
|
China Regenerative Medicine International Ltd
HKEX:8592
|
HK |
|
Shenzhen Envicool Technology Co Ltd
SZSE:002837
|
CN |
|
Blue Dart Express Ltd
NSE:BLUEDART
|
IN |
|
S
|
Shenyang Cuihua Gold and Silver Jewelry Co Ltd
SZSE:002731
|
CN |
|
Beijing LongRuan Technologies Inc
SSE:688078
|
CN |
|
Bajaj Hindusthan Sugar Ltd
NSE:BAJAJHIND
|
IN |
|
O
|
Olympia Industries Bhd
KLSE:OLYMPIA
|
MY |
|
G
|
Guangdong Tecsun Science & Technology Co Ltd
SZSE:002908
|
CN |
|
H
|
Huawen Media Group
SZSE:000793
|
CN |
|
Freight Technologies Inc
NASDAQ:FRGT
|
US |
Balance Sheet
Balance Sheet Decomposition
Suzhou Novosense Microlectronics Co Ltd
Suzhou Novosense Microlectronics Co Ltd
Balance Sheet
Suzhou Novosense Microlectronics Co Ltd
| Dec-2015 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
13
|
17
|
60
|
124
|
78
|
1 265
|
1 751
|
1 074
|
2 559
|
|
| Cash |
0
|
17
|
60
|
124
|
78
|
1 265
|
1 751
|
1 074
|
2 559
|
|
| Cash Equivalents |
13
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
1
|
0
|
3 464
|
2 250
|
2 134
|
1 124
|
|
| Total Receivables |
3
|
2
|
18
|
54
|
138
|
257
|
308
|
519
|
787
|
|
| Accounts Receivables |
3
|
1
|
8
|
42
|
106
|
188
|
179
|
393
|
637
|
|
| Other Receivables |
0
|
1
|
10
|
12
|
31
|
69
|
129
|
126
|
150
|
|
| Inventory |
1
|
8
|
18
|
85
|
224
|
605
|
828
|
833
|
1 476
|
|
| Other Current Assets |
2
|
4
|
11
|
38
|
81
|
132
|
162
|
128
|
232
|
|
| Total Current Assets |
19
|
31
|
107
|
302
|
520
|
5 724
|
5 299
|
4 688
|
6 178
|
|
| PP&E Net |
1
|
10
|
30
|
79
|
233
|
557
|
1 291
|
1 517
|
1 843
|
|
| PP&E Gross |
0
|
10
|
30
|
79
|
233
|
557
|
1 291
|
1 517
|
1 843
|
|
| Accumulated Depreciation |
0
|
3
|
6
|
14
|
38
|
89
|
161
|
261
|
424
|
|
| Intangible Assets |
0
|
0
|
1
|
7
|
22
|
32
|
49
|
394
|
392
|
|
| Goodwill |
0
|
0
|
0
|
38
|
38
|
0
|
0
|
504
|
545
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
247
|
179
|
107
|
0
|
|
| Long-Term Investments |
0
|
5
|
4
|
0
|
0
|
198
|
281
|
387
|
621
|
|
| Other Long-Term Assets |
1
|
0
|
2
|
10
|
29
|
93
|
59
|
77
|
102
|
|
| Other Assets |
0
|
0
|
0
|
38
|
38
|
0
|
0
|
504
|
545
|
|
| Total Assets |
21
N/A
|
46
+118%
|
145
+218%
|
437
+201%
|
841
+92%
|
6 850
+715%
|
7 156
+4%
|
7 674
+7%
|
9 681
+26%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
0
|
1
|
6
|
30
|
74
|
144
|
151
|
272
|
467
|
|
| Accrued Liabilities |
0
|
3
|
7
|
14
|
48
|
118
|
105
|
197
|
324
|
|
| Short-Term Debt |
0
|
3
|
8
|
40
|
94
|
21
|
243
|
11
|
46
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
1
|
17
|
17
|
36
|
70
|
81
|
|
| Other Current Liabilities |
1
|
5
|
11
|
19
|
34
|
27
|
48
|
207
|
134
|
|
| Total Current Liabilities |
2
|
12
|
32
|
105
|
266
|
327
|
584
|
757
|
1 052
|
|
| Long-Term Debt |
0
|
0
|
0
|
9
|
11
|
13
|
337
|
798
|
862
|
|
| Deferred Income Tax |
0
|
0
|
0
|
1
|
1
|
10
|
0
|
49
|
55
|
|
| Minority Interest |
0
|
0
|
0
|
6
|
6
|
1
|
1
|
5
|
18
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
7
|
13
|
29
|
123
|
98
|
|
| Total Liabilities |
2
N/A
|
12
+464%
|
32
+173%
|
120
+275%
|
291
+143%
|
353
+21%
|
950
+169%
|
1 731
+82%
|
2 084
+20%
|
|
| Equity | ||||||||||
| Common Stock |
4
|
6
|
7
|
76
|
76
|
101
|
143
|
143
|
162
|
|
| Retained Earnings |
5
|
9
|
0
|
50
|
274
|
444
|
58
|
345
|
574
|
|
| Additional Paid In Capital |
10
|
19
|
107
|
191
|
200
|
5 953
|
6 206
|
6 161
|
8 137
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
200
|
15
|
128
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Equity |
19
N/A
|
34
+80%
|
113
+234%
|
317
+180%
|
550
+73%
|
6 497
+1 082%
|
6 207
-4%
|
5 942
-4%
|
7 597
+28%
|
|
| Total Liabilities & Equity |
21
N/A
|
46
+118%
|
145
+218%
|
437
+201%
|
841
+92%
|
6 850
+715%
|
7 156
+4%
|
7 674
+7%
|
9 681
+26%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
4
|
101
|
101
|
141
|
141
|
141
|
141
|
143
|
161
|
|